Výsledky vyhledávání - "Domada Ratna Kumar"

Akademický článek

Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia and Parkinson’s disease: A Preliminary Study

Autor: Ashish Kumar Gupta, Komal Rani, Surabhi Swarnkar, Gaurav Khunger Kumar, Mohd Imran Khan, Ruchika Pokhriyal, Domada Ratna Kumar, Vinay Goyal, Manjari Tripathi, Rishab Gupta, Rakesh Kumar Chadda, Perumal Vanamail, Gururao Hariprasad

Publikováno v: Journal of Central Nervous System Disease, Vol 10 (2018)

Aim of the Study: Parkinson’s disease and schizophrenia are disease end points of dopaminergic deficit and hyperactivity, respectively, in the mid brain. Accordingly, current medications aim to restore normal dopamine levels, overshooting of which

Externí odkaz: https://doaj.org/article/67120cecfa604ebf86094206f43898e1

Zobrazit plný text záznamu

Evaluation of α-Synuclein and Apolipoprotein E as Potential Biomarkers in Cerebrospinal Fluid to Monitor Pharmacotherapeutic Efficacy in Dopamine Dictated Disease States of Parkinson’s Disease and Schizophrenia [Corrigendum]

Autor: Ashish Kumar Gupta, Ruchika Pokhriyal, Uddipan Das, Mohd Imran Khan, Domada Ratna Kumar, Rishab Gupta, Rakesh Kumar Chadda, Rashmi Ramachandran, Vinay Goyal, Manjari Tripathi, Gururao Hariprasad

Publikováno v: Neuropsychiatric Disease and Treatment. 18:1271-1272

Gupta AK, Pokhriyal R, Das U, et al. Neuropsychiatr Dis Treat. 2019;15:2073–2085. The authors wish to advise of typographical errors in Figures 1 and 2 and Table 3, the correct unit of apolipoprotein E concentration is μg/ml, and not pg/ml. Page 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe403a8ddc92cb1ea8803bed2bd5f9bc
https://doi.org/10.2147/ndt.s379262

Zobrazit plný text záznamu

Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia

Autor: Vinay Goyal, Gururao Hariprasad, Rakesh K Chadda, Domada Ratna Kumar, Mohd Imran Khan, Ashish Gupta, Rashmi Ramachandran, Rishab Gupta, Manjari Tripathi, Ruchika Pokhriyal

Publikováno v: Neuropsychiatric Disease and Treatment

Aim Parkinson’s disease and schizophrenia are clinical end points of dopaminergic deficit and excess, respectively, in the mid-brain. In accordance, current pharmacological interventions aim to restore normal dopamine levels, the overshooting of wh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e0dde54d0ed243c73f52b76061adfdb
https://doi.org/10.2147/ndt.s214217

Zobrazit plný text záznamu

Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia

Autor: Uddipan Das, Rashmi Ramachandran, Mohd Imran Khan, Rishab Gupta, Gururao Hariprasad, Ruchika Pokhriyal, Rakesh K Chadda, Vinay Goyal, Manjari Tripathi, Ashish Gupta, Domada Ratna Kumar

Publikováno v: Neuropsychiatric Disease and Treatment

Background and objective Dopamine plays an important role in the disease pathology of Parkinson’s disease and schizophrenia. These two neuropsychiatric disorders represent disease end points of the dopaminergic spectrum where Parkinson’s disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1ab45e358be1364657ec44aeac11f81
http://europepmc.org/articles/PMC6650621

Zobrazit plný text záznamu

2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia

Autor: Mohd Imran Khan, Komal Rani, Perumal Vanamail, Ruchika Pokhriyal, Gaurav Kumar, Domada Ratna Kumar, Rakesh K Chadda, Ashish Kumar Gupta, Manjari Tripathi, Vinay Goyal, Rishab Gupta, Ashok Kumar Mohanty, Gururao Hariprasad

Publikováno v: Neuropsychiatric Disease and Treatment. 15:1031-1044

Ashish Kumar Gupta,1 Gaurav Khunger Kumar,1 Komal Rani,1 Ruchika Pokhriyal,1 Mohd Imran Khan,1 Domada Ratna Kumar,1 Vinay Goyal,2 Manjari Tripathi,2 Rishab Gupta,3 Rakesh Kumar Chadda,3 Perumal Vanamail,4 Ashok Kumar Mohanty,5 Gururao Hariprasad1 1De

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f67125d6d08c381af30b00c70d687219
https://doi.org/10.2147/ndt.s198559

Zobrazit plný text záznamu

Cerebrospinal fluid proteomics for identification of potential biomarkers to monitor pharmacological therapeutic efficacy in dopamine dictated disease states of Parkinson's disease and schizophrenia

Autor: Rakesh K Chadda, Rashmi Ramachandran, Domada Ratna Kumar, Gururao Hariprasad, Ruchika Pokhriyal, Ashish Gupta, Mohd Imran Khan, Vinay Goyal

Publikováno v: The FASEB Journal. 32

Parkinson’s disease and schizophrenia are disease end points of dopaminergic deficit and hyperactivity, respectively in the mid brain. Accordingly, current pharmacological interventions aim to rest...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a673b340d5f5f65327f022fb42c1ed1e
https://doi.org/10.1096/fasebj.2018.32.1_supplement.802.4

Zobrazit plný text záznamu

Autor: Gururao Hariprasad, Domada Ratna Kumar, Komal Rani, Surabhi Swarnkar, Ashish Gupta, Vinay Goyal, Rishab Gupta, Mohd Imran Khan, Perumal Vanamail, Ruchika Pokhriyal, Gaurav Kumar, Manjari Tripathi, Rakesh K Chadda

Publikováno v: Journal of Central Nervous System Disease
Journal of Central Nervous System Disease, Vol 10 (2018)

Aim of the Study:Parkinson’s disease and schizophrenia are disease end points of dopaminergic deficit and hyperactivity, respectively, in the mid brain. Accordingly, current medications aim to restore normal dopamine levels, overshooting of which r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bb233dbda15733b40342c1463980ae9
https://doi.org/10.1177/1179573518803585

Zobrazit plný text záznamu

Molecular modeling of Gly80 and Ser80 variants of human group IID phospholipase A2 and their receptor complexes: potential basis for weight loss in chronic obstructive pulmonary disease

Autor: Gururao Hariprasad, Mohd Imran Khan, Manoj Kumar, Abdul S. Ethayathulla, Domada Ratna Kumar, Ashish Kumar Gupta

Publikováno v: Journal of molecular modeling. 22(9)

Weight loss is a well known systemic manifestation of chronic obstructive pulmonary disease (COPD). A Gly80Ser mutation on human group IID secretory phospholipase A2 (sPLA2) enhances expression of the cytokines that are responsible for weight loss. I

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c36834d24865efc0f779b8cce253f49f
https://pubmed.ncbi.nlm.nih.gov/27585677

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání